A study on hospitalized COVID-19 patients who received plasma therapy
To date, the coronavirus disease 2019 (COVID-19) pandemic has claimed more than 38 million lives worldwide. Scientists around the world …
Home » Coronavirus Disease COVID-19 »
Adapting COVID-19 vaccination strategies based on SARS-CoV-2’s evolution
Successfully arresting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative pathogen of coronavirus disease 2019 …
Study links barotrauma to COVID-19 in younger patients
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has multiple and diverse clinical manifestations leading …
Researchers develop a multivalent vaccine for COVID-19 and influenza
Researchers at Duke University, USA, are looking into the possibility of a combined influenza & coronavirus disease 2019 (COVID-19) vaccine …
Study reports on safety of COVID-19 mRNA vaccines in pregnancy
Researchers used different surveillance systems in the United States to track adverse outcomes after coronavirus disease 2019 (COVID-19) vaccination in …
Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants
A team of international scientists recently demonstrated that antibodies generated in response to the DNA vaccine INO-4800 can effectively neutralize …
Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it induced humoral responses in …
Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it induced humoral responses in …
Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?
Several vaccines have been developed, approved and rolled out to prevent coronavirus disease 2019 (COVID-19), caused by severe acute respiratory …
The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants
A research group from the U.S. demonstrated the practicality of a spike display system in order to accelerate vaccine design, …
Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals
The search for effective and safe antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen responsible for the …
Emergence of novel SARS-CoV-2 variants and co-mutations in India
A new study has uncovered genetic changes in a group of similar severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants …
New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants
Scientists in Colombia have identified a new highly divergent SARS-CoV-2 lineage with Spike substitutions L249S and E484K. These same mutations …
Salivary IgG to SARS-CoV-2 after mild COVID-19
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 …
Novel bioinformatics tool could help improve COVID-19 diagnosis
Improved diagnostics are important in containing the ongoing coronavirus disease 2019 (COVID-19) pandemic as well as understanding the biology of …
SARS-CoV-2 escapes host immune responses by modulating dendritic cell maturation
A team of scientists from Italy and the USA has recently explored the maturation pattern of conventional dendritic cells (cDCs) …
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may …
Study assesses causes of higher COVID-mortality among men
Researchers in the United States, Germany and Uganda have conducted a study showing that the factors responsible for a higher …